CLINICAL TRIALS PROFILE FOR DUONEB
✉ Email this page to a colleague
All Clinical Trials for DUONEB
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01933984 ↗ | Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients | Completed | Shin-hwar Wu | N/A | 2013-08-01 | This study evaluates whether individualized dosing schedule of inhaled bronchodilator is more effective than fixed dosing in reducing airway resistance of intubated COPD patients. |
NCT02872597 ↗ | Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus | Completed | University Hospitals Cleveland Medical Center | Phase 1 | 2016-09-05 | This study is a Phase I study to investigate the addition of inhaled Ipratropium bromide to standard therapy in the treatment of severe asthma attacks in children admitted to the Pediatric Intensive Care Unit. Half of the subjects will receive inhaled Ipratropium, and half will receive an inhaled placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DUONEB
Condition Name
Clinical Trial Locations for DUONEB
Trials by Country
Clinical Trial Progress for DUONEB
Clinical Trial Phase
Clinical Trial Sponsors for DUONEB
Sponsor Name